EGFR and lung cancer: Our study only suggested that immunochemotherapy was less effective in patients with liver metastasis, and we believe that this is not unique for EGFR-TKI-resistant NSCLC population as liver metastasis has been widely confirmed as an independent factor of treatment resistance and poor prognosis of lung cancer.